ZURA BIO LIMITED Due from Related Parties, Current
ZURA BIO LIMITED (ZURA) had Due from Related Parties, Current of $5.14 thousand as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Notes
us-gaap:DueFromRelatedPartiesCurrent · last filed 2022-05-13
- 2022-03-31: Due from Related Parties, Current $5.14K.
- 2021-09-30: Due from Related Parties, Current $9.57K.
| Period end | Due from Related Parties, Current |
|---|---|
| 2022-03-31 | $5.14K 10-Q · filed 2022-05-13 |
| 2021-09-30 | $9.57K 10-Q/A · filed 2022-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |